Elekta AB (publ) (STO:EKTA.B)
Sweden · Delayed Price · Currency is SEK 51.00
-1.00 (-1.92%)
Sep 24, 2026, 5:29 PM CET
Elekta AB Market Cap
Elekta AB has a market cap or net worth of 20.25 billion as of September 24, 2026. Its market cap has increased by 3.62% in one year.
Market Cap
20.25B
Enterprise Value
24.82B
Revenue
16.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
51.00
ChartMarket Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 1.51B to 20.25B, an increase of 1,244.30%. That is a compound annual growth rate of 9.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 20.25B | -6.61% |
| Dec 30, 2025 | 21.68B | -7.20% |
| Dec 30, 2024 | 23.36B | -25.72% |
| Dec 29, 2023 | 31.45B | 31.08% |
| Dec 30, 2022 | 23.99B | -45.18% |
| Dec 30, 2021 | 43.77B | 3.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 66.87B |
| Sectra AB | 54.06B |
| Nolato AB | 14.52B |
| Vitrolife AB | 12.57B |
| MedCap AB | 7.99B |
| Xvivo Perfusion AB | 7.56B |
| CellaVision AB | 3.98B |
| BICO Group AB | 1.58B |